glp 1 vomiting Use of GLP-1 agonists prior to THA may increase postoperative nausea, GI Adverse Effects of Glucagon-Like

Front Med (Lausanne) 2020;7:628289

As the Times reported, Eli Lilly, which manufactures Mounjaro a similar medication that is approved for treating diabetes but also induces weight loss announced on Sept

Nassar, M., Nassar, O., Abosheaishaa, H

Some had hoped that its efficacy would more closely resemble that of existing injections on the market which can result in up to a 20% body weight loss while others noted the trial drop-out rate of 12% due to side effects or personal reasons

Patients should be counseled that these medications are not recommended during pregnancy or lactation

Per Shed's Terms (6) and HIPAA Notice: Shed Holdings, LLC and the Provider Group are covered by HIPAA obligations and Shed's Privacy Policy